What is JUVÉDERM VOLUMA™ XC?
JUVÉDERM VOLUMA™ XC enters the US marketplace! The FDA has approved the first and only Hyaluronic Acid (HA) filler for use in correcting age-related volume loss in the cheeks, for patients over the age of 21. The product is known as Voluma® XC, and has already been in use in 72 other countries around the world since 2009. It is a gel that is similar in consistency to the well-known filler, Juvederm®, but Voluma® XC gives a subtle lift specifically to the cheek area, helping to restore contour and provide a more youthful profile for up to 2 years! This significant longevity, coupled with the safe and well known product characteristics of other gel injectables, may prove to be a radically new addition to the long-lasting filler market. Much like its close cousin, Juvederm®, the Voluma® XC is combined with lidocaine to provide additional comfort during injection.
The American Academy of Facial Esthetics is excited about Voluma® XC’s release in the US marketplace, as we always want to stay on top of the most current products available for our members, faculty, and attendees. As members of the elite Black Diamond club with Allergan, Dr. Louis Malcmacher in conjunction with the American Academy of Facial Esthetics, is ranked amongst the top 1% of practices in the nation, due to excellence with results and volume of Botox® and Juvederm®.